Topics - Drug Discovery
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
Published May 17, 2013
Will leverage chemical and biological expertise Read More »
Published May 16, 2013
Will combine chemistry and engineering with biocatalysis expertise Read More »
Published May 15, 2013
Expands discovery services in Asia Pacific Read More »
Published May 10, 2013
Will use immune assay to identify biomarkers in cells of cancer patients Read More »
Published May 3, 2013
Will use Ambrx's protein med-chem tech Read More »
Published April 23, 2013
To develop HD-001 cancer program Read More »
Published April 22, 2013
Will utilize Evotec's technology platform for three more years Read More »
Published April 15, 2013
Aims to identify novel small molecule and antibody targets Read More »
Published April 11, 2013
Dalton to synthesize and manufacture selected drug candidates Read More »
Published April 5, 2013
Will use conjugation technology to develop ADCs in oncology Read More »
Published April 3, 2013
Will develop and commercialize multiple Accurins Read More »
Published March 28, 2013
Aims to identify candidates to treat drug abuse and pain Read More »
Published March 28, 2013
Aims to identify new approaches to metabolic disease Read More »
Published March 22, 2013
Gains license to antibodies and linker technology Read More »
Published March 21, 2013
Aims to discover, develop and commercialize oncology therapies Read More »
